ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
Por um escritor misterioso
Descrição
ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New
Issue Brief: Treating Opioid Use Disorder in Justice-Involved Populations - Justice Community Opioid Innovation Network Coordination and Translation Center
Ananda Scientific (@AnandaScience) / X
ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
States Should Measure Opioid Use Disorder Treatment to Improve Outcomes
FDA-Approved Medications for the Treatment of OUD
Google Pilots Opioid Addiction Moonshot in Dayton, Ohio - Bloomberg
IJMS, Free Full-Text
States Should Measure Opioid Use Disorder Treatment to Improve Outcomes
ANANDA Scientific
ANANDA Scientific
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Final Report
de
por adulto (o preço varia de acordo com o tamanho do grupo)